Clinical outcomes of progressive supranuclear palsy and multiple system atrophy (original) (raw)

Journal Article

,

1Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, 2Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, 3Sara Koe PSP Research Centre, Institute of Neurology, University College London, London, UK, 4Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus) and 5Department of Neurosciences, Monash Medical Centre, Melbourne, Australia

Search for other works by this author on:

,

1Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, 2Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, 3Sara Koe PSP Research Centre, Institute of Neurology, University College London, London, UK, 4Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus) and 5Department of Neurosciences, Monash Medical Centre, Melbourne, Australia

Search for other works by this author on:

,

1Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, 2Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, 3Sara Koe PSP Research Centre, Institute of Neurology, University College London, London, UK, 4Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus) and 5Department of Neurosciences, Monash Medical Centre, Melbourne, Australia

Search for other works by this author on:

,

1Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, 2Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, 3Sara Koe PSP Research Centre, Institute of Neurology, University College London, London, UK, 4Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus) and 5Department of Neurosciences, Monash Medical Centre, Melbourne, Australia

Search for other works by this author on:

,

1Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, 2Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, 3Sara Koe PSP Research Centre, Institute of Neurology, University College London, London, UK, 4Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus) and 5Department of Neurosciences, Monash Medical Centre, Melbourne, Australia

Search for other works by this author on:

,

1Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, 2Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, 3Sara Koe PSP Research Centre, Institute of Neurology, University College London, London, UK, 4Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus) and 5Department of Neurosciences, Monash Medical Centre, Melbourne, Australia

Search for other works by this author on:

,

1Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, 2Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, 3Sara Koe PSP Research Centre, Institute of Neurology, University College London, London, UK, 4Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus) and 5Department of Neurosciences, Monash Medical Centre, Melbourne, Australia

Search for other works by this author on:

1Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, 2Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, 3Sara Koe PSP Research Centre, Institute of Neurology, University College London, London, UK, 4Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus) and 5Department of Neurosciences, Monash Medical Centre, Melbourne, Australia

Search for other works by this author on:

Received:

10 December 2007

Revision received:

29 February 2008

• • Article contents
  • Figures & tables
  • Video
  • Audio
  • Supplementary Data
• Cite

Cite

S. S. O'Sullivan, L. A. Massey, D. R. Williams, L. Silveira-Moriyama, P. A. Kempster, J. L. Holton, T. Revesz, A. J. Lees, Clinical outcomes of progressive supranuclear palsy and multiple system atrophy, Brain, Volume 131, Issue 5, May 2008, Pages 1362–1372, https://doi.org/10.1093/brain/awn065
Close

Navbar Search Filter Mobile Enter search term Search

Abstract

Prognostic predictors have not been defined for progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). Subtypes of both disorders have been proposed on the basis of early clinical features. We performed a retrospective chart review to investigate the natural history of pathologically confirmed cases of PSP and MSA. Survival data and several clinically relevant milestones, namely: frequent falling, cognitive disability, unintelligible speech, severe dysphagia, dependence on wheelchair for mobility, the use of urinary catheters and placement in residential care were determined. On the basis of early symptoms, we subdivided cases with PSP into ‘Richardson's syndrome’ (RS) and ‘PSP-parkinsonism’ (PSP-P). Cases of MSA were subdivided according to the presence or absence of early autonomic failure. Sixty-nine (62.7%) of the 110 PSP cases were classified as RS and 29 (26.4%) as PSP-P. Of the 83 cases of MSA, 42 (53.2%) had autonomic failure within 2 years of disease onset. Patients with PSP had an older age of onset (P< 0.001), but similar disease duration to those with MSA. Patients with PSP reached their first clinical milestone earlier than patients with MSA (P< 0.001). Regular falls (P< 0.001), unintelligible speech (P = 0.04) and cognitive impairment (P = 0.03) also occurred earlier in PSP than in MSA. In PSP an RS phenotype, male gender, older age of onset and a short interval from disease onset to reaching the first clinical milestone were all independent predictors of shorter disease duration to death. Patients with RS also reached clinical milestones after a shorter interval from disease onset, compared to patients with PSP-P. In MSA early autonomic failure, female gender, older age of onset, a short interval from disease onset to reaching the first clinical milestone and not being admitted to residential care were independent factors predicting shorter disease duration until death. The time to the first clinical milestone is a useful prognostic predictor for survival. We confirm that RS had a less favourable course than PSP-P, and that early autonomic failure in MSA is associated with shorter survival.

© The Author (2008). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Topic:

• phenotype
• parkinson disease
• deglutition disorders
• age of onset
• cognition disorders
• male
• multiple system atrophy
• parkinsonian disorders
• signs and symptoms
• speech
• progressive supranuclear palsy
• wheelchairs
• patient prognosis
• gender
• treatment outcome
• cognitive impairment
• pure autonomic failure
• urinary catheters
• mobility
• medical records review
• illness length

You do not currently have access to this article.

Personal account

• Sign in with email/username & password
• Get email alerts
• Save searches
• Purchase content
• Activate your purchase/trial code
• Add your ORCID iD

Get help with access

Institutional access

Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:

IP based access

Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.

Sign in through your institution

Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.

1. Click Sign in through your institution.
2. Select your institution from the list provided, which will take you to your institution's website to sign in.
3. When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
4. Following successful sign in, you will be returned to Oxford Academic.

If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.

Sign in with a library card

Enter your library card number to sign in. If you cannot sign in, please contact your librarian.

Society Members

Society member access to a journal is achieved in one of the following ways:

Sign in through society site

Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:

1. Click Sign in through society site.
2. When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
3. Following successful sign in, you will be returned to Oxford Academic.

If you do not have a society account or have forgotten your username or password, please contact your society.

Sign in using a personal account

Some societies use Oxford Academic personal accounts to provide access to their members. See below.

Personal account

A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Some societies use Oxford Academic personal accounts to provide access to their members.

Viewing your signed in accounts

Click the account icon in the top right to:

• View your signed in personal account and access account management features.
• View the institutional accounts that are providing access.

Signed in but can't access content

Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.

Institutional account management

For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.

Purchase

Short-term Access

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

Clinical outcomes of progressive supranuclear palsy and multiple system atrophy - 24 Hours access

EUR €51.00

GBP £44.00

USD $55.00

Rental

This article is also available for rental through DeepDyve.

Citations

Views

Altmetric

Metrics

Total Views 11,393

8,192 Pageviews

3,201 PDF Downloads

Since 12/1/2016

Citations

295 Web of Science

×

Email alerts

Citing articles via

• Latest

• Most Read

• Most Cited

More from Oxford Academic